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Summary: The influence of 2-(3-methyl-cinnamyl-hydrazono)-propionate on the utilization of various sub-
strates in isolated rat hemidiaphragms was investigated in comparison with other hypoglycaemic compounds.
The effect of 2-(3-methyl-cinnamyl-hydrazono)-propionate was concentration-dependent. At a concentration
of 0.5 mmol/1 2-(3-methyl-cinnamyl-hydrazono)-propionate, glucose utilization increased from 0.276 ± 0.043
μηιοί · g"1 · I""1 to 0.894 + 0.303 μιηοΐ · g"1 · Γ1 (ρ < 0.05). Pyruvate and lactate utilization were stimulated
to a lesser extent, while acetate utilization remained nearly constant. At a concentration of 2 mmol/1 2-(3-
methyl-cinnamyl~hydrazono)-propionate, the oxidation of palmitate decreased from 0.214 ± 0.017 μηιοί
. g-i. j-i to 0.060 ± 0.005 μηιοί · g"1 · I"1, while the oxidation of octanoate was not decreased. These findings
point to a stimulation of the glycolytic flux by inhibition of long-chain fatty acid oxidation.
Introduction · _ . * · . , , , , , ,In previous studies it has been shown that hydrazo-
2-(3-Methyl-cinnamyl-hydrazono)-propionate and nopropionic acids produce a strong hypoglycaemic
other hypoglycaemic substances with different sites of effect in various laboratory animals (3, 4, 17, 18). In
action in glucose and fatty acid metabolism can be guinea pigs and rats 2-(3-methyl-cinnamyl-hydra-
used to study the interrelationships of fatty acid and zono)-propionate showed a reduction of gluconeo-
glucose metabolism. Furthermore, 2-(3-methyl-cin- genesis in perfused liver and isolated liver cells (3,16),
namyl-hydrazono)-propionatemay be of potential use inhibition of jejunal glucose uptake (2) and elevation
as an orail antidiabetic drug. of plasma free fatty acids (4).
In guinea pigs, a decrease of hepatic acetyl-CoA and
') For previous publications see I.e. (2-5,10,17,18) ketone body concentration in serum (4), and a de-
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crease of long-chain fatty acid oxidation in perfused
liver (11,15) have been observed. From measurements
of metabolite concentrations in liver extracts it ap-
pears that the carnitine-dependent mitochondrial up-
take of long-chain fatty acids is inhibited (3). An
inhibition of carnitine-acylcarnitine translocase in
liver mitochondria by 2-(3-methyl-cinnamyl-hydra-
zono)-propionate was recently reported (5).
According to the concept of the "glucose-fatty acid
cycle" (1, 6, 7, 8) inhibitors of fatty acid oxidation
should increase glucose utilization and lower blood
glucose concentration primarily when fatty acids are
being used as the major substrates.
The effect of 2-(3-methyl-cinnamyl-hydrazono)-pro-
pionate on glycolysis and fatty acid oxidation in mus-
cle has not previously been described; the purpose of
the present study was to investigate this by measuring
the conversion of 14C-labelled substrates to carbon
dioxide in hemidiaphragms of rats. Increased glucose
consumption in muscle may make a large contribution
to the hypoglycaemic effect of 2-(3-methyl-cinnamyl-
hydrazono)-propionate.
For purposes of comparison we tested three more
substances (fig. 1): 2-bromopalmitate and clomoxir,
two known inhibitors of long-chain fatty acid oxi-
dation, and 3-methyl-cinnamyl-hydrazine, the corre-












Fig. 1. Structural formulae.
Materials and Methods
Materials
Hydroxide of hyamine and Insta-Fluor were purchased from
Packard Instruments International S.A. (Zurich, Switzerland);
labelled compounds (Z)-[U-14C]glucose, [l-14C]palmitic acid, and
sodium salt of [l-14C]pyruvic acid, £>,Ml-14C]lactic acid, [1-
14C]acetic acid) and [l-14C]octanoic acid) from Amersham* Buch-
ler (Braunschweig, W-Germany); fatty acid-free bovine serum
albumin and sodium salt of palmitic and caprylic acid (octanoic
acid) from Sigma Chemical Company (St. Louis, U.S.A.);
sodium salt of L-lactic acid from Serva (Heidelberg, W-Ger-
many); 2-bromopalmitate from Aldrich Chemical Company
(Milwaukee, U.S.A.); unlabelled substrates and all further
chemicals from E. Merck A.G. (Dannst^t, W-Germany). 2-
(3-Methyl-cinnamylr-hydrazono)-propionate, and 3-methyl-cin-
namyl-hydrazine were generously provided by Boehringer
Mannheim GmbH (Mannheim, W-Germany). Clomoxir (so-
dium 2-[5r(4-chlorophenyl)pentyl)]oxirane-2-carboxylate) was
made available by Byk Gulden GmbH (Konstant W-Ger-
many).
Animals
Male Lewis rats weighing 180—300 g from Zentrales Tierlabor
of the Medizinische Hochschule Hannover were used. Rats were
fasted 48 hours before killing, except in one experiment with
non-fasted animals.
Experimental procedure
During the preparation of rat diaphragms, Erlenmeyer flasks
containing 2 ml of incubation medium (see below) were prein-
cubated for 15 minutes at 37 °C.
Rats were killed by decapitation or a blow on the neck and
diaphragms excised. After removal of residual blood and fat,
hemidiaphragms were rinsed, and placed in ice-cold Krebs-
Ringer phosphate buffer for 15 minutes. One hemidiaphragm
of each rat was subsequently incubated with test substance (test
diaphragm), the other was incubated without (control). Hemi-
diaphragms were gently blotted and weighed. An Erlenmeyer
flask with 2 ml of incubation medium was prepared for each
hemidiaphragm. The incubation medium was gassed with 100%
oxygen and the hemidiaphragms were placed immediately in
this gassed medium. The Erlenmeyer flasks were instantly closed
with a rubber stopper, carrying a small glass trough. The trough
contained 0.3 ml hydroxide of hyamine for the absorption of
released carbon dioxide. The Erlenmeyer flasks were continu-
ously incubated in shaking incubator at 37 °C. After one hour
shaking was interrupted, 0.6 ml of 0.6 mol/i perchloric acid
was injected into the flasks (penetrating the rubber stopper with
an injection needle) and shaking was continued for another
hour. The flasks were carefully opened, and the trough, con-
taining hyamine, was placed in a counting vial containing
scintillation liquid Insta-Fluor (10 ml). The disintegrations per
minute were registered in a beta counter (Tri-carb 460 CD,
Liquid Scintillation System, Packard Instruments Company,
Illinois, U. S.A.) and related to l g of diaphragm (wet weight).
The quantity of I4C-labelled substrate converted to carbon
dioxide per l g diaphragm during l h incubation time was
calculated from the specific activity.
Incubation medium
Control hemidiaphragms were incubated in Krebs-Ringer phos-
phate buffer gassed with 100% oxygen, containing one of the
following substrates:
5.0 mmol/1 jD-[U-I4C]glucose (specific activity: 3.7 GBq/rnol)
1.0 mmol/1 L-[l-14C]lactate (specific activity: 9.25 GBq/mol),
1.0 mmol/1 [l-14C]pyruvate (specific activity: 18.5 GBq/mol),
2.0 mmol/1 [l-I4C]acetate (specific activity: 4.63 GBq/mol),
2.0 mmol/1 [l-14C]palmitate (specific activity: 18.5 GBq/mol),
or
2.0 mmol/1 [l-14C]pctanoate (specific activity: 18.5 GBq/mol).
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In accordance with Frayn et al. (9) experiments were performed
with 4 g/1 fatty acid-free bovine serum albumin in the incubation
medium, unless otherwise indicated. Incubations with palmitate
or octanoate were performed in the presence of 40 g/1 albumin,
to ensure the dissolution of these fatty acids.
In experiments with test hemidiaphragms 2-(3-methyl-cinna-
myl-hydrazono)-propionate or another test substance was
added to the medium described for controls. Concentrations
are given in figures 2 and 3 and in tables 1 and 2.
Results
The effect of 2-(3-methyl-cinnamyl-hydrazono)-pro-
pionate on glucose oxidation in comparison with
other hypoglycaemic substances is shown by table 1.
Tab. 1. Effect of various substances (2mmol/l) on glucose ox-
idation in hemidiaphragms of rats. Incubations and
measurement of glucose oxidation were performed as
described under "Materials and Methods". Results of






































* Differs significantly from its corresponding control value
(p < 0.05, t-test).
/*""* f~*
% increase of glucose oxidation = · 100
Gc
Gc: glucose oxidation of hemidiaphragms incubated in medium
(control).
GT: glucose oxidation of hemidiaphragms incubated in medium
containing test substance.
Conversion of glucose to carbon dioxide depended
upon the concentration of 2-(3^methyl-cinnamyl-hy-
drazpno)-propionate. A significant enhancement of
glucose utilization was observed at a concentration
as low as 0.1 mmol/l 2-(3-methyl-cinnamyl-hydra-
zono)-propionate (p < 0.005) (fig. 2). The concentra-
tion-dependence of glucose conversion to carbon
dioxide is shown in figure 2. There was a statistically
significant difference between the effect of 0.1 and 0.5
mmol/l, 0.5 and 1.0 mmpl/1, and between that of 1.0
and 2.0 mmol/l 2^(3-methyl-cinnamyl-hydrazono)^
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Fig. 2. Concentration-dependent effect of 2-(3-methyl-cinna-
myl-hydrazono)-propionate on glucose utilization.
Incubations and measurement of glucose utilization
were performed as described under "Materials and
Methods".
Unshaded columns: controls, χ ± s
Shaded columns: various concentrations of 2-(3-methyl-
cinnamyl-hydrazono)-propionate, χ ± s
In four experiments with 2-(3-methyl-cinnamyl-hy-
drazono)-propionate, glucose oxidation was com-
pared with the oxidation of lactate, pyruvate, and
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Fig. 3. Utilization of glucose, lactate, pyruvate, and acetate in
the presence of 2-(3-methyl-cinnamyl-hydrazono)-pro-
pionate.
Incubations and measurement of glucose utilization
were performed as described under "Materials and
Methods".
Unshaded columns: controls, χ ± s
Shaded columns: 0.5 mmol/l 2-(3-melhyl"Cinnamyl-hy-
drazono)-propionate, χ ± s
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The influence of 2-(3-methyl-cinnamyl-hydrazono)-
propionate and other hypoglycaemic substances on
long-chain fatty acid oxidation is shown in table 2.
Tab. 2. Effect of various hypoglycaemic substances (2 mmol/1)
on palmitate oxidation in hemidiaphragms of rats. In-
cubations and measurement of palmitate oxidation
were performed as described under "Materials and
Methods". Results of "palmitate converted to CO2" are





































* Differs significantly from its corresponding control value
(p < 0.05, t-test).
% decrease of palmitate oxidation PC-PT 100
PC: palmitate oxidation of hemidiaphragms incubated in me-
dium (control).
PT: palmitate oxidation of hemidiaphragms incubated in me-
dium containing test substance.
In one experiment diaphragms were incubated in a
medium with octanoate. The carbon dioxide produc-
tion from octanoate was 0.066 ± 0.007 μπιοί · g"1
• h~J in controls, compared with 0.077 + 0.004 μπιοί
• g""1 -h"1 in test diaphragms incubated in the pres-
ence of 2-(3-methyl-cinnamyl-hydrazono)-propio-
nate. While 2-(3-methyl-cinnamyl-hydrazono)-pro-
pionate induced a decrease of palmitate oxidation
there was a slight increase of octanoate oxidation.
In a further experiment with fed rats, glucose utili-
zation was enhanced from 0.460 ± 0.151 μπιοί - e"1
Data from our study show that this substance causes
a concentration-dependent increase of glucose utilis-
ation in rat diaphragms (fig. 2). Haeckel et al. (10)
found a concentration-dependent effect on glycolysis
in human leukocytes.







compound that lowers blood glucose levels by mul-
tifactorial action. The contribution of accelerated gly-
colysis in muscle to the decrease in blood glucose after
treatment with 2-(3-methyl-cinnamyl-hydrazono)-
propionate was not investigated so far.
Clomoxir, which was compared
namyl-hydrazono)-propionate under these experi-
mental conditions, showed a similar enhancement of
glucose oxidation (tab. 1). However, the effect of the
corresponding hydrazine (3-methyl-cinnamyl-hydra-
zine) on glucose utilization was much weaker (tab. 1).
In this context, it has to be considered that the protein
binding of 3-methyl-cinnamyl-hydrazine (protein-
bound fraction: 0.05) was even lower than that of 2-
(3-methyl-cinnarnyl-hydrazono)-propionate (protein-
bound fraction 0.20) (unpublished results). This cor-
responds to results from experiments with fasted
guinea pigs (4), where significant hypoglycaemic ef-
fects were achieved only in the presence of 2-(3-
methyl-cinnamyl-hydrazono)-propionate. With 3-
methyl-cinnamyl-hydrazineno effect on blood glucose
level could be observed in the latter study (4).
2-(3-Methyl-cinnamyl-hydrazono)-propionate was
shown to be an inhibitor of fatty acid oxidation (11,
3, 5) in guinea pig liver. In the present study various
experiments were performed to determine whether the
increase of glucose oxidation in muscle could be ex-
plained by the effect on fatty acid oxidation.
In fasted or diabetic animals fatty acids are used as
the major substrates for energy metabolism. If the
effect of 2-(3-methyl-cinnarnyl-hydrazono)-propio-
nate on glucose oxidation is mediated by a reduction
of fatty acid metabolism it should be more pro-
nounced in fasted than in fed rats. This was confirmed
by our experiments, since glucose oxidation was in-
creased by 360% in diaphragms of fasted (tab. 1),
but only by 157% in diaphragms of fed rats.
To investigate directly, whether 2-(3-methyl-cinnamyl-
hydrazono)-propionate influences the metabolism of
long-chain fatty acids in muscle, diaphragms were
incubated in a medium containing palmitate.. Like
clomoxir and 2-bromopalmitate (6, 7), tested for rea-
sons of comparison, 2-(3-methyl-cinnamyl-hydra-
zono)-propionate induced a highly significant de-
crease of palmitate utilization (tab. 2). However, the
oxidation of short- or medium-chain fatty acids like
acetate or octanoate was not decreased by 2-(3-
methyl-cinnamyl-hydrazono>propionate. According
to Pande (1975), Ramsey et al. (1975), and Murthy et
al. (1984), carnitine acylcarnitine translocase is in-
volved in the carnitine-dependent import of long-
chain acyl groups like palmitate into mitochondria.
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On the other side the transport of short-chain fatty
acids and octanoate does not require the participation
of carnitine (19) or carnitine acylcarnitine translocase.
So the finding that this hydrazone decreases the oxi-
dation of long-chain but not of short- or medium-
chain fatty acids points to an inhibition of long-chain
fatty acid transport into mitochondria. An inhibition
of carnitine acylcarnitine translocase by 2-(3-methyl-
cinnamyl-hydrazono)-propionate has already been
demonstrated with mitochondria from guinea pig liver
(5).
To obtain further insight into the mechanism of glu-
cose utilization in fasted rats under the influence of
2-(3-methyl-cinnamyl-hydrazono)-propionate, var-
ious substrates were employed. Highly significant in-
creases of pyruvate (p < 0.01) and lactate (p < 0.05)
utilization were observed, but there was only an in-
significant enhancement of acetate consumption. This
points to a direct or indirect activation of the pyruvate
dehydrogenase complex or to a decrease of a preex-
isting inhibition of this enzyme.
As demonstrated in figure 3, the stimulation of glu-
cose oxidation is much higher than that of lactate or
pyruvate. This suggests that an additional enzyme,
regulating the glycolytic flux, may be influenced by
2-(3-methyl-cinnamyl-hydrazono)-propionate. A de-
crease of hepatic citrate and acetyl-CoA concentra-
tions has been shown in experiments with fasted
guinea pigs (3, 4). It can be speculated that under
conditions of increased metabolism of long-chain
fatty acids 2-(3-methyl-cinnamyl-hydrazono)-pro-
pionate may lower elevated concentrations of citrate
and acetyl-CoA in muscle also. In this way the inhi-
bition of phosphofructokinase and pyruvate dehydro-
genase may be decreased and glucose utilization be
accelerated.
Our results suggest that the blood glucose lowering
effect of 2-(3-methyl-cinnamyl-hydrazono)-propio-
nate may be based not only on inhibition of hepatic
gluconeogenesis, and jejunal resorption of glucose,
but also on a marked increase of the glucose oxidation
in muscle. Like some other hypoglycaemic substances
(6, 8, 12, 13, 14) 2-(3-methyl-cinnamyl-hydrazono)-
propionate may increase glucose utilization in muscle
by decreasing the oxidation of long-chain fatty acids
according to the "glucose-fatty acid cycle" (1).
2-(3-Methyl-cinnamyl-hydrazono)-propionate has
been shown to inhibit hepatic carnitine-acylcaraitine
translocase (5). It remains to be established whether
the described effect of 2-(3-methyl-cinnamyl-hydra-
zono)-propionate on palmitate oxidation in muscle is
also due to an inhibition of translocase-mediated
transport of long-chain fatty acids.
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